| NDC Code | 43742-1377-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-1377-1) |
|---|
| Product NDC | 43742-1377 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Addiclenz |
|---|
| Non-Proprietary Name | Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Bisphenol A, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Phosphoricum Acidum, Selenium Metallicum, Zincum Metallicum, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methyl Paraben, Propyl Paraben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum, Bacillus Thuringiensis (bt Toxin) |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20180828 |
|---|
| End Marketing Date | 20240618 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Deseret Biologicals, Inc. |
|---|
| Substance Name | ARSENIC TRIOXIDE; ASPARTAME; BACILLUS THURINGIENSIS; BENZALKONIUM CHLORIDE; BETA VULGARIS; BISPHENOL A; CHELIDONIUM MAJUS; COBALT; COPPER; FORMALDEHYDE; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE |
|---|
| Strength | 12; 30; 14; 30; 3; 12; 3; 12; 12; 30; 12; 12; 12; 30; 30; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC] |
|---|